SCHEMBL1412435

SCHEMBL1412435

COC(=O)c1nnn(Cc2ccc(OC)cc2)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
CYP1A2 P05177 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
POLB P06746 3/20 0.52
MAPT P10636 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
HSD17B10 Q99714 4/20 0.52
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 3/20 0.52
HPGD P15428 3/20 0.52
DRD2 P14416 3/20 0.50
DRD4 P21917 3/20 0.50
HTR2A P28223 3/20 0.50
DRD3 P35462 3/20 0.50
RECQL P46063 1/20 0.47
PDE8B O95263 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4226447 0.90 CYP19A1 (0.56) ALOX15L3MBTL1SMN1; SMN2MEN1KMT2A
SCHEMBL17351879 0.88 ALOX15 (0.56) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL18321160 0.86 CYP1A2 (0.55) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL22815606 0.86 ALOX15 (0.58) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL26089434 0.86 ALOX15 (0.58) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL23319912 0.86 ALOX15 (0.58) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL18457359 0.86 CYP1A2 (0.73) CYP1A2SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL22815572 0.85 ALOX15 (0.57) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL1412461 0.84 ALOX15 (0.56) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1
SCHEMBL23484362 0.84 ALOX15 (0.56) ALOX15L3MBTL1CYP1A2SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS PHOENIX TISSUE REPAIR, INC. 2023-05-11 US disclosed
WO-2020257487-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2020-12-24 WO disclosed
EP-1991542-B1 HERBICIDAL ISOXAZOLINE COMPOUNDS SYNGENTA LTD (GB) 2011-03-16 EP disclosed
US-20100004128-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-01-07 US disclosed
US-20100004128-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-01-07 US disclosed
US-20100004128-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS SYNGENTA CROP PROTECTION, INC. (US) 2010-01-07 US disclosed
EP-1991542-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS Syngenta Limited (GB) 2008-11-19 EP disclosed
WO-2007096576-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS SYNGENTA LIMITED (GB) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143491-A1 TRIAZOLE GLYCOLATE OXIDASE INHIBITORS XDH, DUOX1, PNPO ALOX15 71/4885L3MBTL1 2586/4885CYP1A2 179/4885
US-20100004128-A1 HERBICIDAL ISOXAZOLINE COMPOUNDS CYP4X1, RDX, HAX1 ALOX15 2655/4885L3MBTL1 2350/4885CYP1A2 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.